<DOC>
	<DOCNO>NCT00957957</DOCNO>
	<brief_summary>This study examine change various gut-derived hormone obese type 2 diabetic patient elective bariatric surgery .</brief_summary>
	<brief_title>Gut Hormone Profiling Obese Patients With Type 2 Diabetes ( MK-0000-134 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Obesity , Morbid</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Documented type 2 diabetes total disease duration â‰¤10 year BMI least 35 kg/m^2 Patient surgical candidate either RYGBP , GBS vertical sleeve gastrectomy ( VSG ) Any illness might confound result study pose additional risk patient participation History stroke , seizure , major neurological disorder History cancer Patient use use medication alter body weight Patient unwilling unable follow study procedure</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>